Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy

SIMPLE SUMMARY: Patients diagnosed with pancreatic cancer have a poor prognosis at time of diagnosis, with a 5-year survival rate of merely 10%. The only treatment with curative intent is surgical resection of the tumor and adjacent tumor-containing lymph nodes. To improve surgical outcome and survi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dam, Martijn A., Vuijk, Floris A., Stibbe, Judith A., Houvast, Ruben D., Luelmo, Saskia A. C., Crobach, Stijn, Shahbazi Feshtali, Shirin, de Geus-Oei, Lioe-Fee, Bonsing, Bert A., Sier, Cornelis F. M., Kuppen, Peter J. K., Swijnenburg, Rutger-Jan, Windhorst, Albert D., Burggraaf, Jacobus, Vahrmeijer, Alexander L., Mieog, J. Sven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656821/
https://www.ncbi.nlm.nih.gov/pubmed/34885196
http://dx.doi.org/10.3390/cancers13236088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656821/
https://www.ncbi.nlm.nih.gov/pubmed/34885196
http://dx.doi.org/10.3390/cancers13236088

Ejemplares similares